Milan, April 22, 2026 – Zambon, a leading chemical and pharmaceutical multinational, is showcasing its dedication to women’s health through an immersive design installation titled ‘Tracce di Cura’ (Traces of Care) at Fuorisalone 2026. The exhibition, part of the Interni Materiae event at the University of Milan (Via Festa del Perdono 7), will run from April 20th to 30th.
‘Tracce di Cura’: An Architectural Journey into Women’s Well-being
Conceived by Amdl Circle and inspired by the ideographic architecture of Michele De Lucchi, the ‘Tracce di Cura’ installation is a compelling blend of contrasting elements. It features the precision of composite aluminum surfaces juxtaposed with the materiality of hand-crafted plaster sculptures within its niches.
The structure, constructed from wooden frames clad in warm white alucobond panels, forms a small, habitable architectural space with a distinct entrance, exit, and four junctions, each leading to an exhibition niche. Within these spaces, feminine silhouettes emerge, symbolizing freedom and self-care. These figures are brought to life from the sketches of Masahiko Cubo, a long-standing contributor to Monurelle’s visual identity, and are presented through video drawings utilizing traditional Japanese techniques.
The installation transforms the archetypal facade of a house into a branched plan, inviting visitors to embark on unconventional journeys filled with discoveries. This narrative artfully conveys Zambon’s unwavering commitment to women’s care, well-being, and overall health.
New Monurelle Line: Tailored Solutions for Women’s Health
The Fuorisalone event also serves as a platform for Zambon to announce the official launch of its new Monurelle line, exclusively dedicated to women’s health and well-being. According to a company press release, this comprehensive line offers solutions designed to support women throughout their lives, addressing specific health needs with targeted efficacy.
The new Monurelle line will be available in Italian pharmacies starting at the end of May. It is backed by robust clinical evidence demonstrating its safety and efficacy, building upon Zambon’s extensive experience in the gynecological field, particularly in the realm of urinary tract infections.
Massimo Grandi, Chief Core Therapies Officer at Zambon, emphasized the company’s development philosophy: “What these products have in common is a development approach focused on scientific quality, safety, and sustainability. From formulations developed according to clinical evidence to production technologies with reduced environmental impact, the line reflects an integrated vision of health. Women’s health requires listening, expertise, and rigorously constructed solutions: with Monurelle, we want to contribute to a culture of prevention and well-being that combines science, responsibility, and individual care.”
Key Products in the Monurelle Line
The new line encompasses a range of innovative products:
- Monurelle* Plus AF: A medical device featuring an exclusive formulation that synergistically acts on both the bladder and intestines. It is designed for the treatment and prevention of cystitis. This product has recognized medical and scientific support and is included in the 2026 European Association of Urology (EAU) guidelines as an effective strategy for reducing symptoms and recurrences, underscoring its clinical evidence and appropriate use.
- Monurelle* CBD oleogel and Monurelle* CBD suppositories: These medical devices provide supportive treatment for female genitourinary syndromes. They address vulvovaginal discomfort, irritation, dryness, atrophy, burning, and conditions associated with vulvodynia. Monurelle* CBD is free of estrogen or substances with hormonal activity, ensuring a valid efficacy and tolerability profile.
- Monurelle* Natural Iron: A dietary supplement specifically formulated to meet women’s iron needs, particularly during critical periods such as childbearing and premenopause. The product boasts 100% natural iron sourced from Italian spirulina, cultivated in photobioreactors-a technology that guarantees high-quality standards and a reduced environmental impact. Studies indicate high bioaccessibility and bioavailability, coupled with a favorable tolerability profile.
This initiative by Zambon at Fuorisalone 2026 not only highlights its commitment to innovation in women’s health but also reinforces Milan’s position as a hub for design and forward-thinking solutions.
Source: lamilano.it
